Literature DB >> 3196510

Cardiac disuse atrophy during LVAD pumping.

M Kinoshita1, H Takano, Y Taenaka, H Mori, S Takaichi, H Noda, E Tatsumi, A Yagura, H Sekii, T Akutsu.   

Abstract

The authors investigated morphologic changes of myocardial tissue of goats supported with a long-duration left ventricular assist device (LVAD). The bypass flow rates of the LVAD were kept at maximum levels (about 80% of total cardiac output) in four goats for 30 days, and at a limited flow rate (around 60%) in one goat each for 30 and 90 days. Morphometric studies using light and electron microscopy were performed on the left ventricles, comparing them to those in the four control studies. The results disclosed: 1) relative volume densities of the myocytes and interstitial tissue in the myocardium were unchanged; 2) cross-sectional areas of the myocytes in the maximum bypass cases were significantly reduced in comparison with pre-experimental data; 3) relative myocyte volumes, calculated by myocytes and nuclear volume densities, were reduced in three goats in the maximum bypass group; and 4) relative volume density of myofibrils was reduced in the maximum and 90 day bypass groups, whereas that of mitochondria was reduced only in the 90 day bypass case. These results indicate that LVADs cause cardiac atrophy which correlates with bypass flow rate and duration of assistance.

Entities:  

Mesh:

Year:  1988        PMID: 3196510

Source DB:  PubMed          Journal:  ASAIO Trans        ISSN: 0889-7190


  10 in total

1.  Superior performance of a paraaortic counterpulsation device compared to the intraaortic balloon pump.

Authors:  John V Terrovitis; Christos E Charitos; Elias J Tsolakis; Paraskevi Dolou; Charalampos N Pierrakos; Kostas X Siafakas; John N Nanas
Journal:  World J Surg       Date:  2003-11-05       Impact factor: 3.352

2.  The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies.

Authors:  Carlo R Bartoli; Robert D Dowling
Journal:  Cardiol Clin       Date:  2011-11       Impact factor: 2.213

Review 3.  Continuous internal counterpulsation as a bridge to recovery in acute and chronic heart failure.

Authors:  Christos D Kontogiannis; Konstantinos Malliaras; Chris J Kapelios; Jay W Mason; John N Nanas
Journal:  World J Transplant       Date:  2016-03-24

4.  Comparison of continuous-flow and pulsatile-flow left ventricular assist devices: is there an advantage to pulsatility?

Authors:  Allen Cheng; Christine A Williamitis; Mark S Slaughter
Journal:  Ann Cardiothorac Surg       Date:  2014-11

Review 5.  Proteasome biology and therapeutics in cardiac diseases.

Authors:  Sanket Kumar Shukla; Khadija Rafiq
Journal:  Transl Res       Date:  2018-09-28       Impact factor: 7.012

Review 6.  Physiologic effects of continuous-flow left ventricular assist devices.

Authors:  Aaron H Healy; Stephen H McKellar; Stavros G Drakos; Antigoni Koliopoulou; Josef Stehlik; Craig H Selzman
Journal:  J Surg Res       Date:  2016-01-20       Impact factor: 2.192

Review 7.  Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New "Gold Standard"?

Authors:  Massimo Capoccia
Journal:  J Cardiovasc Dev Dis       Date:  2016-12-12

Review 8.  Rat Heterotopic Heart Transplantation Model to Investigate Unloading-Induced Myocardial Remodeling.

Authors:  Xuebin Fu; Adrian Segiser; Thierry P Carrel; Hendrik T Tevaearai Stahel; Henriette Most
Journal:  Front Cardiovasc Med       Date:  2016-10-19

9.  Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy.

Authors:  Dian J Cao; Nan Jiang; Andrew Blagg; Janet L Johnstone; Raj Gondalia; Misook Oh; Xiang Luo; Kai-Chun Yang; John M Shelton; Beverly A Rothermel; Thomas G Gillette; Gerald W Dorn; Joseph A Hill
Journal:  J Am Heart Assoc       Date:  2013-04-08       Impact factor: 5.501

10.  Simulation of dilated heart failure with continuous flow circulatory support.

Authors:  Yajuan Wang; Natasha Loghmanpour; Stijn Vandenberghe; Antonio Ferreira; Bradley Keller; John Gorcsan; James Antaki
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.